| Literature DB >> 31084283 |
Taro Yasumoto1,2, Yusaku Takamura3, Mayumi Tsuji2, Takahiro Watanabe-Nakayama4, Keiko Imamura5,6,7, Haruhisa Inoue5,6,7, Shiro Nakamura8, Tomio Inoue8, Atsushi Kimura1,2, Satoshi Yano1, Hisao Nishijo3, Yuji Kiuchi2, David B Teplow9, Kenjiro Ono1.
Abstract
Amyloid β-protein (Aβ) molecules tend to aggregate and subsequently form low MW (LMW) oligomers, high MW (HMW) aggregates such as protofibrils, and ultimately fibrils. These Aβ species can generally form amyloid plaques implicated in the neurodegeneration of Alzheimer disease (AD), but therapies designed to reduce plaque load have not demonstrated clinical efficacy. Recent evidence implicates amyloid oligomers in AD neuropathology, but the precise mechanisms are uncertain. We examined the mechanisms of neuronal dysfunction from HMW-Aβ1-42 exposure by measuring membrane integrity, reactive oxygen species (ROS) generation, membrane lipid peroxidation, membrane fluidity, intracellular calcium regulation, passive membrane electrophysiological properties, and long-term potentiation (LTP). HMW-Aβ1-42 disturbed membrane integrity by inducing ROS generation and lipid peroxidation, resulting in decreased membrane fluidity, intracellular calcium dysregulation, depolarization, and impaired LTP. The damaging effects of HMW-Aβ1-42 were significantly greater than those of LMW-Aβ1-42. Therapeutic reduction of HMW-Aβ1-42 may prevent AD progression by ameliorating direct neuronal membrane damage.-Yasumoto, T., Takamura, Y., Tsuji, M., Watanabe-Nakayama, T., Imamura, K., Inoue, H., Nakamura, S., Inoue, T., Kimura, A., Yano, S., Nishijo, H., Kiuchi, Y., Teplow, D. B., Ono, K. High molecular weight amyloid β1-42 oligomers induce neurotoxicity via plasma membrane damage.Entities:
Keywords: Alzheimer disease; amyloid β-protein; membrane disruption
Mesh:
Substances:
Year: 2019 PMID: 31084283 DOI: 10.1096/fj.201900604R
Source DB: PubMed Journal: FASEB J ISSN: 0892-6638 Impact factor: 5.191